| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/12/2006 | EP1645289A1 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/12/2006 | EP1645285A2 Therapeutical use of anti-mag antibody for the treatment of ischemic stroke |
| 04/12/2006 | EP1645284A1 Use of ligands of the antigen CDw52 for the treatment of diseases that are related to degenerated macrophages |
| 04/12/2006 | EP1645183A1 Process for producing human-origin immunocompetent cell |
| 04/12/2006 | EP1644740A1 Assessment of skeletal growth using measurements of nt-cnp peptides |
| 04/12/2006 | EP1644729A2 Anti-cd74 immunoconjugates and methods |
| 04/12/2006 | EP1644492A2 Modified recombinant vaccinia viruses and other microorganisms, uses thereof |
| 04/12/2006 | EP1644487A1 Regulatory t-cells containing galectins for the therapy and diagnosis of diseases |
| 04/12/2006 | EP1644417A2 Humanized immunoglobulin loci |
| 04/12/2006 | EP1644416A2 Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses |
| 04/12/2006 | EP1644415A2 Antibodies against interleukin-22 and uses therefor |
| 04/12/2006 | EP1644414A2 Binding molecules against sars-coronavirus and uses thereof |
| 04/12/2006 | EP1644413A2 Modified antibody fragments |
| 04/12/2006 | EP1644412A2 Modified antibody fab fragments |
| 04/12/2006 | EP1644407A1 Uses of a novel eimeria gene and corresponding protein |
| 04/12/2006 | EP1644405A1 Recombinant expression of streptococcus pyogenes cysteine protease and immunogenic compositions thereof |
| 04/12/2006 | EP1644404A2 Antigenic peptides of sars coronavirus and uses thereof |
| 04/12/2006 | EP1644044A2 Modified antibody fragments |
| 04/12/2006 | EP1644039A2 Compositions and methods for treating coagulation related disorders |
| 04/12/2006 | EP1644018A2 Soluble clca-1 and antagonists to clca-1 |
| 04/12/2006 | EP1643894A2 Methods, kits and antibodies for detecting parathyroid hormone |
| 04/12/2006 | EP1250435B1 Human neurexin-like proteins and polynucleotides encoding the same |
| 04/12/2006 | EP1237926A4 Human antibodies as detection reagents |
| 04/12/2006 | EP1192247B1 Sphingosine kinase enzyme |
| 04/12/2006 | EP1140968B1 Dna molecules encoding splice variants of the human melanocortin 1 receptor protein |
| 04/12/2006 | EP1140175B1 Antibodies to truncated vegf-d and uses thereof |
| 04/12/2006 | EP0972042B1 Polypeptide expressed in the horny layer of epidermis and use thereof |
| 04/12/2006 | EP0950062B1 Protein markers for esophageal cancer |
| 04/12/2006 | EP0866878B1 Detection of mammary tumor virus-like sequences in human breast cancer |
| 04/12/2006 | CN1759186A Purification of polypeptides |
| 04/12/2006 | CN1759123A Uses of IL-23 agonists and antagonists; related reagents |
| 04/12/2006 | CN1757724A Use of multiple recombination sites with unique specificity in recombinational cloning |
| 04/12/2006 | CN1757653A Anti-HBeAg monoclonal antibody and its cell strain, prepn. method and use thereof |
| 04/12/2006 | CN1757652A Antienterotoxin C2 nanoclonal antibodies, and its application |
| 04/12/2006 | CN1757413A Antibody inhibition body fluid immunity of using special integrated CD40CR(CD40 part) |
| 04/12/2006 | CN1250717C Human Enzymes of metalloprotease family |
| 04/12/2006 | CN1250572C Anti-body capable to selectively detect prion PrPsc isoforms |
| 04/12/2006 | CN1250571C Specific binding molecules for scintigraphy, conjugates containing them and uses |
| 04/12/2006 | CN1250570C Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 04/12/2006 | CN1250288C Beta glycan as an inhibin receptor and uses thereof |
| 04/12/2006 | CN1250286C Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 04/11/2006 | US7026457 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 04/11/2006 | US7026456 p75 heterodimer specific anti-human Interleukin-12 (IL-12) antibodies that are characterized by higher potency and greater efficacy in neutralizing human IL-12 bioactivity than known heterodimer specific IL-12 monoclonal antibodies; use treating autoimmune disorders |
| 04/11/2006 | US7026455 Anti-pro 1343 antibodies |
| 04/11/2006 | US7026454 Polypeptide of given sequence that is a biochemical marker for prostate cancer conjugated to an antibody or fragment thereof; treating prostate cancer |
| 04/11/2006 | US7026452 Human mitochondrial proteins and polynucleotides encoding the proteins |
| 04/11/2006 | US7026451 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 04/11/2006 | US7026450 Ma family polypeptides and anti-Ma antibodies |
| 04/11/2006 | US7026449 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/11/2006 | US7026446 Chimeric antibody conjugate comprising an antigen binding region of a non-human antibody and an immunoglobulin constant region which comprises at least one CH domain or epitope thereof, where the constant region is not a naturally occurring FC fragment; useful as positive control reagents in immunoassays |
| 04/11/2006 | US7026445 Human SDF-5 protein and compositions |
| 04/11/2006 | US7026289 Method and compositions for treating hyperlipidemia and other conditions |
| 04/11/2006 | US7026283 Calcium-independent negative regulation by CD81 of receptor signalling |
| 04/11/2006 | US7026151 Cat kidney disease marker |
| 04/11/2006 | US7026140 Serum paraoxonase |
| 04/11/2006 | US7026139 To regulate an immune response in an animal |
| 04/11/2006 | US7026134 Contacting the sample with the conjugate and an antibody capable of binding atleast one epitope of oxycodone and its metabolite, and detecting the bound conjugate |
| 04/11/2006 | US7026130 screening chemical compounds for ability to compete with hepatitis C virus for binding to a HCV receptor by comparing the binding of the HCV receptor to the E2 protein of HCV in the presence of said compound to the binding of the receptor to the protein in the absence of the compound |
| 04/11/2006 | US7026129 IG lambda biopolymer markers predictive of Alzheimers disease |
| 04/11/2006 | US7026127 Reg-like protein |
| 04/11/2006 | US7025968 Identifying viricidal agents which prevent cytomegalo viral infection and distribution; gene expression inhibition |
| 04/11/2006 | US7025962 Gene encoding lymphocyte surface antigen; protein or nucleic acid |
| 04/11/2006 | US7025961 Anti-plasmodium composition and methods of use |
| 04/11/2006 | US7025959 Drug containing Dna coding of protein; hybrids; genetic engineering |
| 04/11/2006 | CA2259967C Peptide reagent for the detection of human cytomegalovirus (cmv) |
| 04/11/2006 | CA2204375C Methods for the diagnosis of glaucoma |
| 04/06/2006 | WO2006037048A2 Fc RECEPTOR HOMOLOG ANTIBODIES AND USES THEREOF |
| 04/06/2006 | WO2006037038A1 Optimized vaccines to provide protection against ebola and other viruses |
| 04/06/2006 | WO2006036922A2 Srage mimetibody, compositions, methods and uses |
| 04/06/2006 | WO2006036834A2 MODIFIED Fc MOLECULES |
| 04/06/2006 | WO2006036822A1 A method for identifying agents which modulate cell growth or survival |
| 04/06/2006 | WO2006036745A2 Il-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses |
| 04/06/2006 | WO2006036213A2 The use of gammaglobulin for the treatment of periodontal disease |
| 04/06/2006 | WO2006035741A1 Gene expressed specifically in es cells and utilization of the same |
| 04/06/2006 | WO2006035702A1 C-peptide specific binding molecule and use thereof |
| 04/06/2006 | WO2006035687A1 Method of constructing transgenic bird |
| 04/06/2006 | WO2006035681A1 HLA-A11-RESTRICTED Tax ANTITUMOR EPITOPES |
| 04/06/2006 | WO2006035273A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 04/06/2006 | WO2006026470A3 Hiv immunostimulatory compositions |
| 04/06/2006 | WO2005116076A3 Neoplasm-specific polypeptides and their uses |
| 04/06/2006 | WO2005115452A9 Fcϝriib-specific antibodies and methods of use thereof |
| 04/06/2006 | WO2005114216A3 Stamp2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 04/06/2006 | WO2005111081A3 Immunoglobulin-like variable chain binding polypeptides and methods of use |
| 04/06/2006 | WO2005097162A3 Steroid sparing agents and their use |
| 04/06/2006 | WO2005095453A3 Specific binding members against synaptophysin |
| 04/06/2006 | WO2005077980A3 Soluble tcr-like molecules and their uses |
| 04/06/2006 | WO2005062871A3 Tat linear epitope peptides and conjugates thereof for use in therapeutic compositions and assays |
| 04/06/2006 | WO2005026203A3 Dna promoters and anthrax vaccines |
| 04/06/2006 | WO2005018572A3 Improved antibodies having altered effector function and methods for making the same |
| 04/06/2006 | WO2005012877A3 Systems and methods for antibody engineering |
| 04/06/2006 | WO2005000225A3 Production of rabies antibodies in plants |
| 04/06/2006 | WO2004108078A3 Rationally designed antibodies |
| 04/06/2006 | WO2004093831A3 Cytokine-expressing cellular vaccine combinations |
| 04/06/2006 | WO2004076621A3 Compositions of nucleic acids for treating and detecting influenza virus |
| 04/06/2006 | WO2004050837A3 Treatment of dna damage related disorders |
| 04/06/2006 | US20060075521 Method of producing and screening antibodies produced in transgenic plants |
| 04/06/2006 | US20060074234 Isolated mammalian membrane protein genes; related reagents |
| 04/06/2006 | US20060074233 Detect binding with cells transfected with DNA |
| 04/06/2006 | US20060074229 Monoclonal antibodies induce apoptosis |
| 04/06/2006 | US20060074228 antibody specifically binds to a polypeptide used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors |